ThermoGenesis Holdings, Inc., a California-based medical organization, develops and markets automated technologies for cell-based therapies, including CAR-T immunotherapy.
ThermoGenesis Holdings, Inc., based in Rancho Cordova, California, develops and markets automated technologies for cell-based therapies, including chimeric antigen receptor (CAR-T) immunotherapy. The company offers a suite of solutions for automated clinical biobanking, point-of-care applications, and automation for immuno-oncology. Notably, its semi-automated, functionally closed CAR-TXpress platform streamlines the manufacturing process for the emerging CAR-T immunotherapy market.
ThermoGenesis Holdings has made significant strides in the medical technology sector, particularly in advancing the automation of cell-based therapies. Its innovative CAR-TXpress platform has positioned the company as a key player in the immunotherapy space, enhancing the efficiency and scalability of CAR-T cell manufacturing. The company's impact is evident in its contributions to improving therapeutic outcomes and expanding access to cutting-edge treatments.

Kincell Bio
kincellbio.com

Cellino
cellinobio.com

Cellares
cellares.com

Tr1x
tr1x.bio

Targazyme
targazyme.com

HebeCell
hebecellcorp.com

Cartesian Therapeutics

Celularity
celularity.com

Allogene Therapeutics
allogene.com

Histogen
histogen.com

BioCardia

Cell Care Therapeutics
cell-care.com

Cell BioEngines
cellbioengines.com

Geneius
geneius.com

Spheringenics
Companies similar to ThermoGenesis Holdings include Kincell Bio, Cellino, Cellares and Tr1x.
ThermoGenesis Holdings was founded in 1987.
ThermoGenesis Holdings' headquarters is located in Rancho Cordova, CA, US.
ThermoGenesis Holdings has 38 employees as of Feb 6, 2024.